DNA methylation and leukemia susceptibility in China: Evidence from an updated meta‑analysis

Jiang,Danjie; Li,Yirun; Hong,Qingxiao; Shen,Yusheng; Xu,Chunjing; Xu,Yan; Zhu,Huangkai; Dai,Dongjun; Ouyang,Guifang; Duan,Shiwei

doi:10.3892/mco.2016.959

DNA methylation and leukemia susceptibility in China: Evidence from an updated meta‑analysis

Authors:
- Danjie Jiang
- Yirun Li
- Qingxiao Hong
- Yusheng Shen
- Chunjing Xu
- Yan Xu
- Huangkai Zhu
- Dongjun Dai
- Guifang Ouyang
- Shiwei Duan
View Affiliations

Affiliations: Medical Genetics Center, School of Medicine, Ningbo University, Ningbo, Zhejiang 315211, P.R. China, Department of Hematology, Ningbo First Hospital, Ningbo, Zhejiang 315010, P.R. China
Published online on: July 12, 2016 https://doi.org/10.3892/mco.2016.959
Pages: 193-207

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mounting evidence supports a role for DNA methylation in the pathogenesis of leukemia; however, there no overview of these results in the Chinese population. The present study performed a comprehensive meta‑analysis to establish candidate genes with an altered methylation status in Chinese leukemia patients. Eligible studies were identified through searching the National Center of Biotechnology Information PubMed and Wanfang databases. Studies were pooled and overall odds ratios with corresponding confidence intervals were calculated. A total of 4,325 leukemia patients and 2,010 controls from 94 studies on 53 genes were included in this meta‑analysis, and 47 genes were found to be aberrantly methylated in leukemia patients. A further subgroup meta‑analysis by leukemia subtype demonstrated that hypermethylation of 5 genes, namely cyclin‑dependent kinase (CDKN)2A, DNA-binding protein inhibitor‑4, CDKN2B, glioma pathogenesis-related protein 1 and p73, contributed to the risk of various subtypes of leukemia. In addition, a strong association between CDKN2A and leukemia was identified in Chinese (P<0.00001) but not in European patients. The aberrantly methylated genes identified in the present meta‑analysis may help elucidate the mechanisms underlying the development of leukemia in Chinese patients.

View Figures

View References

1	Davis AS, Viera AJ and Mead MD: Leukemia: An overview for primary care. Am Fam Physician. 89:731–738. 2014.PubMed/NCBI
2	Zhong S, Chen Z, Yu X, Chen W, Lv M, Ma T and Zhao J: Tea consumption and leukemia risk: A meta-analysis. Tumour Biol. 35:5205–5212. 2014. View Article : Google Scholar : PubMed/NCBI
3	Greim H, Kaden DA, Larson RA, et al: The bone marrow niche, stem cells, and leukemia: Impact of drugs, chemicals, and the environment. Ann NY Acad Sci. 1310:7–31. 2014. View Article : Google Scholar : PubMed/NCBI
4	Laurier D, Grosche B, Auvinen A, et al: Childhood leukaemia risks: From unexplained findings near nuclear installations to recommendations for future research. J Radiol Prot. 34:R53–R68. 2014. View Article : Google Scholar : PubMed/NCBI
5	Malinge S, Chlon T, Doré LC, et al: Development of acute megakaryoblastic leukemia in Down syndrome is associated with sequential epigenetic changes. Blood. 122:e33–e43. 2013. View Article : Google Scholar : PubMed/NCBI
6	Wakeford R: The risk of childhood leukaemia following exposure to ionising radiation - a review. J Radiol Prot. 33:1–25. 2013. View Article : Google Scholar : PubMed/NCBI
7	Woo JS, Alberti MO and Tirado CA: Childhood B-acute lymphoblastic leukemia: A genetic update. Exp Hematol Oncol. 3:162014. View Article : Google Scholar : PubMed/NCBI
8	Bhatia S: Disparities in cancer outcomes: Lessons learned from children with cancer. Pediatr Blood Cancer. 56:994–1002. 2011. View Article : Google Scholar : PubMed/NCBI
9	Carranza C, Granados L, Morales O, et al: Frequency of the ETV6-RUNX1, BCR-ABL1, TCF3-PBX1, and MLL-AFF1 fusion genes in Guatemalan pediatric acute lymphoblastic leukemia patients and their ethnic associations. Cancer Genet. 206:227–232. 2013. View Article : Google Scholar : PubMed/NCBI
10	Goggins WB and Lo FF: Racial and ethnic disparities in survival of US children with acute lymphoblastic leukemia: Evidence from the SEER database 1988–2008. Cancer Causes Control. 23:737–743. 2012. View Article : Google Scholar : PubMed/NCBI
11	Kennedy AE, Kamdar KY, Lupo PJ, et al: Genetic markers in a multi ethnic sample for childhood acute lymphoblastic leukemia risk. Leuk Lymphoma. 56:169–174. 2014. View Article : Google Scholar : PubMed/NCBI
12	Savage SA: Genomic clues to ethnic differences in ALL. Blood. 123:2440–2442. 2014. View Article : Google Scholar : PubMed/NCBI
13	Lim JY, Bhatia S, Robison LL and Yang JJ: Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia. Cancer. 120:955–962. 2014. View Article : Google Scholar : PubMed/NCBI
14	Adkins RM, Krushkal J, Tylavsky FA and Thomas F: Racial differences in gene-specific DNA methylation levels are present at birth. Birth Defects Res A Clin Mol Teratol. 91:728–736. 2011. View Article : Google Scholar : PubMed/NCBI
15	Xia YY, Ding YB, Liu XQ, et al: Racial/ethnic disparities in human DNA methylation. Biochim Biophys Acta. 1846:258–262. 2014.PubMed/NCBI
16	Baylin SB and Jones PA: A decade of exploring the cancer epigenome - biological and translational implications. Nat Rev Cancer. 11:726–734. 2011. View Article : Google Scholar : PubMed/NCBI
17	Plass C, Pfister SM, Lindroth AM, et al: Mutations in regulators of the epigenome and their connections to global chromatin patterns in cancer. Nat Rev Genet. 14:765–780. 2013. View Article : Google Scholar : PubMed/NCBI
18	Jiang D, Hong Q, Shen Y, et al: The diagnostic value of DNA methylation in leukemia: A systematic review and meta-analysis. PLoS One. 9:e968222014. View Article : Google Scholar : PubMed/NCBI
19	Higgins JP, Thompson SG, Deeks JJ and Altman DG: Measuring inconsistency in meta-analyses. BMJ. 327:557–560. 2003. View Article : Google Scholar : PubMed/NCBI
20	Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H and Moons KG: More than numbers: The power of graphs in meta-analysis. Am J Epidemiol. 169:249–255. 2009. View Article : Google Scholar : PubMed/NCBI
21	Pluta A, Nyman U, Joseph B, Robak T, Zhivotovsky B and Smolewski P: The role of p73 in hematological malignancies. Leukemia. 20:757–766. 2006. View Article : Google Scholar : PubMed/NCBI
22	Cahill N and Rosenquist R: Uncovering the DNA methylome in chronic lymphocytic leukemia. Epigenetics. 8:138–148. 2013. View Article : Google Scholar : PubMed/NCBI
23	Esteller M: CpG island hypermethylation and tumor suppressor genes: A booming present, a brighter future. Oncogene. 21:5427–5440. 2002. View Article : Google Scholar : PubMed/NCBI
24	Zhao Y, Guo J, Zhang X, et al: Downregulation of p21 in myelodysplastic syndrome is associated with p73 promoter hypermethylation and indicates poor prognosis. Am J Clin Pathol. 140:819–827. 2013. View Article : Google Scholar : PubMed/NCBI
25	Volodko N, Gordon M, Salla M, Ghazaleh HA and Baksh S: RASSF tumor suppressor gene family: Biological functions and regulation. FEBS Lett. 588:2671–2684. 2014. View Article : Google Scholar : PubMed/NCBI
26	Benezra R, Davis RL, Lockshon D, Turner DL and Weintraub H: The protein Id: A negative regulator of helix-loop-helix DNA binding proteins. Cell. 61:49–59. 1990. View Article : Google Scholar : PubMed/NCBI
27	Bodoor K, Haddad Y, Alkhateeb A, et al: DNA hypermethylation of cell cycle (p15 and p16) and apoptotic (p14, p53, DAPK and TMS1) genes in peripheral blood of leukemia patients. Asian Pac J Cancer Prev. 15:75–84. 2014. View Article : Google Scholar : PubMed/NCBI
28	Chmelařová M, Křepinská E, Spaček J, Laco J, Nekvindová J and Palička V: Methylation analysis of tumour suppressor genes in ovarian cancer using MS-MLPA. Folia Biol (Praha). 58:246–250. 2012.PubMed/NCBI
29	Cechova H, Lassuthova P, Novakova L, et al: Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia. Neoplasma. 59:168–174. 2012. View Article : Google Scholar : PubMed/NCBI
30	Deligezer U, Erten N, Akisik EE and Dalay N: Methylation of the INK4A/ARF locus in blood mononuclear cells. Ann Hematol. 85:102–107. 2006. View Article : Google Scholar : PubMed/NCBI
31	Hsiao PC, Liu MC, Chen LM, et al: Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan. Chin J Physiol. 51:27–31. 2008.PubMed/NCBI
32	Zheng R, Shen S, Shen J and Ma X: Studies on p16, p15, p18 and p19 methylation of INK4 series cancer inhibitive gene in leukemia. J Fujian Med Univ. 38:257–260. 2004.
33	Xiao Y, Liu Y, Jiang L and Ran L: Study on the deletion point mutation and promoter methylation analysis of p16 in leukemia. Guizhou Med J. 34:784–787. 2010.
34	Yang J, Li X, Sun L, Song G, Chen H and Liu Y: Expression of p16 gene in adult acute leukemia. J Zhengzhou Univ (Med Sci Ed.). 38:33–36. 2003.
35	Song G, Yang J, Sun H, Liu C, Chen H and Li X: Deletion and methylation of p16 gene in an adult acute leukemia. Henan J Oncol. 17:229–231. 2004.
36	Tan G and Guo X: Methods of CpG islands methylation detection. J Jinan Univ. 22:24–26. 2001.
37	Zhu C, Xu W, Liu D, Wang Y and Bi K: Study of the methylation of p15 and p16 gene in acute leukemia. Shandong Med J. 45:4–5. 2005.
38	Zhang J, Wu J and Tan Y: The relationship between P16 gene inactivation and expression of mRNA in ALL. J Wenzhou Med Coll. 30:5–7. 2000.
39	Fan L, Shen J, Ye B, et al: Detection of p16 gene methylation status in adult patients with acute leukemia by using n-MSP. J Exp Hematol. 15:258–261. 2007.
40	Jiang J, Shen J, Yan J, et al: The value of p15 gene methylation in minimal residual disease of childhood acute leukemia by MSP. China Child Blood. 7:1–3. 2002.
41	Meng Y, Yu H, Guo C, et al: Quantitative analysis of p15 and p16 gene methylation and mRNA expression levels in acute leukemia patients. Chin J Hematol. 26:434–435. 2005.
42	Wang B: The clinical significance of p16 gene methylation in leukemia and other hematologic malignancies. Master's degree dissertation, China Medical University. 2002.
43	Yin Y: The clinical significance of p15 gene methylation in leukemia and other hematologic malignancies. Master's degree dissertation, China Medical University. 2002.
44	Chen H, Sun H, Liu C, Liu Y, Song G and Li X: Methylation of p16/p15 exon 2 in adult acute myeloid leukemia. J Zhengzhou Univ (Med Sci Ed.). 38:722–724. 2003.
45	Lin F, Ye B, Shen J, et al: Detection of p15 methylation and deletion status in acute lymphoblastic leukemia using hn-MSP. J Leuk Lymphoma. 21:208–212. 2012.
46	Zhu C, Bi K and Liu X: Homozygous deletion and methylation of P15 gene in acute laukemia. Shandong Med J Shandong Yiyao. 41:10–11. 2001.
47	Shen Z, Zhang J, Yu K and Jiang S: Evaluation of methylation-specific polymerase chain reaction and its potential clinical value in detecting minimal residual disease of adult acute leukemia with P15. J Wenzhou Med Coll. 32:230–232. 2002.
48	Fan H, Guo X, Tan G, Wu Q, Zhou T and Guo Q: Study on methylation of p15 INK4B in myelodysplastic syndrome. Chin J Pathophysiol. 17:349–352. 2001.
49	Tong H and Lin M: Methylation of p15INK4B gene and its mechanism in patients with myelodysplastic syndrome and leukemia. Chin J Pathophysiol. 20:2257–2260. 2004.
50	Guo X, Fan H, Wu Q, et al: Study on methylation of p15INK4B gene in acute myeloid leukemia and chronic myeloid leukemia. J Exp Hematol. 8:257–260. 2000.
51	Qiao S, Xu S, Guo X and Wang Y: Clinical significance of the expression of DNA methyltransferase genes (DNMT) in acute leukemia patients. J Exp Hematol. 13:260–265. 2005.
52	Chen F and Zeng X: Detection of p15 gene hypermethylation in acute leukemia by MSP. Chin J Hematol. 21:2502000.
53	Yin Y, Li Y and Liu D: The clinical significance of p15 gene methylation in leukemia and other hematologic malignancies. Chin J Hematol. 24:383–384. 2003.
54	Wu D: p15INK4b gene DNA methylation and histone modification mechanism of leukemia cell mediated by p15-piRNAs. PhD dissertation, Fujian Medical University. 2013.
55	Wang H: The study of p15 gene methylation in malignancies. Master's degree dissertation, Qingdao University. 2002.
56	Zhao Y, Wang QS, Li HH, et al: [Significance of id4 promoter methylation in monitoring AML patients with completely remission]. J Exp Hematol. 16:476–478. 2008.
57	Wang X, Kang H, Cen J, Li Y, Wang L and Yu L: Methylation Status of id4 gene promoter in patients with chronic myeloid leukemia. J Exp Hematol. 18:1402–1404. 2010.
58	Liu F, Xu R, Cui X, Zhang X and Wang Y: ID4 promoter methylation in acute myeloid leukemia. J Exp Hematol. 19:582–584. 2011.
59	Jie X: WT1, ID4, GLIPR1 aberrant gene promoter methylation and mRNA expression in leukemia patients. Master's degree dissertation, Guangdong Medical College. 2012.
60	Zhao Y: The significance of Id4 gene methylation in hematological malignancies. PhD dissertation, PLA Postgraduate Medical School. 2005.
61	Xiao YH, Li XH, Tan T, et al: Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis. J Cancer Res Clin Oncol. 137:1831–1840. 2011. View Article : Google Scholar : PubMed/NCBI
62	Liang T, Tan T, Xiao Y, et al: Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia. J Cent South Univ (Med Sci Ed.). 34:388–394. 2009.
63	Zhang Y, Gao Y, Wang X, et al: The relationship between p73 gene methylation and childhood acute leukemia. Proceedings of the Ninth National Conference on Environmental and Occupational Medicine Graduate (Shanghai, China). 254–256. 2010.
64	Zhang H, Mo W and Yang Z: The expression of WWOX and p73 in acute myeloid leukemia. Guangdong Med J. 33:1567–1570. 2012.
65	Wu C, Jin J, Ji Y, et al: Abnormal expression and significance of p73 gene in adult acute lymphoblastic leukemia. Jiangsu Med J. 34:339–341. 2008.
66	Liu J, Jiang Y, Xu W and Liang X: Alterations of p53 and p73 genes in lympho-plasmacytic diseases. Pract Clin Med. 6:9–13. 2005.
67	Xu W: Study on methylation of the p73 gene in acute lymphoblastic leukemia and its clinical significances. Chin J Pract Int Med. 25:905–906. 2005.
68	Yu G: Abnormal expression of p73 gene in adult acute lymphoblastic leukemia. Med Innov Chin. 2:121–122. 2014.
69	Xie X, Chen Z, Zhang X and Huang M: Detecting methylation of the calcitonin gene in monitoring treatment and disease evolution for myelogenous leukemia. Chin J Cancer. 22:616–619. 2003.
70	Tang Y, Deng C, Du Q and Li G: Study on hypermethylation of the calcitonin gene in malignant hematological disorders. J West Chin Univ Med Sci. 32:86–88. 2001.
71	Wang S, Hong W and Peng A: The study of CT gene methylation in chronic myeloid leukemia. Chin J Hematol. 19:321998.
72	Qian J, Yao D, Lin J, et al: Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia. J Exp Hematol. 18:1390–1394. 2010.
73	Niu Y, Wang P, Wang Y, Wang Y, Cai D and Li Y: Expression of death-associated protein kinase gene and methylation status of promoter region in acute leukimia. J Exp Hematol. 22:30–34. 2014.
74	Zhao W: DAPK gene promoter methylation, expression and biological function in acute leukemia. PhD dissertation, Southern Medical University. 2009.
75	Qian J, Wang YL, Lin J, Yao DM, Xu WR and Wu CY: Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol. 82:119–123. 2009. View Article : Google Scholar : PubMed/NCBI
76	Lin W, Ye Z and Tan J: Gene methylation abnormalities in chronic lymphocytic leukemia patients by PCR. J Qiqihar Med Coll. 31:2376–2377. 2010.
77	Wu B, Chen E and Zhu B: Detecting the aberrant methylation of progesterone receptor B gene in human chronic lymphocytic leukemia by MSP. Chin J Hemorheol. 18:140–141. 2008.
78	Zhang X: The experimental study of PR promoter CpG island methylation in leukemia. Master's degree dissertation, Third Military Medical University. 2003.
79	Shi X, Chang N, Fan Y, et al: Detection and clinical significance of SFRP2 promoter methylation status in patients with acute myeloid leukemia. Chin J Clin, Electron Ed. 5:1962–1966. 2011.
80	Wang H, Zhang G, Yao K, et al: The gene methylation and protein expression of SFRP5 in leukemic cells. J China Med Univ. 41:2012.
81	Xu C, Shen J, Shen S, Fu H, Zhu Y and Chen L: The significance of methylation status of secreted frizzled-related protein gene promoter in acute leukemia. Chin J Intern Med. 49:769–771. 2010.
82	Li M: A preliminary study of inactivation of IGSF4 gene methylation in leukemia cell. PhD dissertation, PLA Postgraduate Medical School. 2004.
83	Chen W, Huang C, Zhan X, et al: RASSF1A gene methylation and its clinical significance in leukemia patients. Lab Med. 27:554–556. 2012.
84	Song J, Li Y, Yang Z, Yang L and Chen J: Hypermethylation in SFRP2 promoter in human leukemia K562 cells and bone marrow specimen with chronic myeloid leukemia. Acad J Third Med Coll PLA. 33:2583–2586. 2011.
85	Dou L: The study of LRP15 gene methylation in blood diseases. Master's degree dissertation, PLA Postgraduate Medical School. 2004.
86	Yao C, Fang J, Gao L, Ding J, Shu G and Yu W: Study on the relationship between the RIZ1 gene expression and methylation status of the gene promoter in acute myeloid leukemia. J Southeast Univ (Med Sci Ed.). 29:119–122. 2010.
87	Cai F: RIZ1 gene expression and promoter methylation status in acute childhood leukemia. PhD dissertation, Huazhong University Science and Technology. 2012.
88	Shi X, Fan Y, Zhou C, et al: Study of abnormal methylation in the promoter region of SFRP4 gene in acute myeloid leukemia. Chin J Clin, Electron Ed. 5:990–995. 2011.
89	Dou LP, Liu JH, Wang C, et al: [Study on the involvement of ZO-1 gene in leukemogenesis]. Chin J Hematol. 30:473–476. 2009.
90	Wang C, Wang G, Tan Y, Li W, Liu C and Yu L: The methylation pattern and clinical significance of Zonula occludens-1 gene promoter in acute leukemia. Chin J Intern Med. 47:111–113. 2008.
91	Chim CS, Wong SY, Pang A, et al: Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia. 19:2241–2246. 2005. View Article : Google Scholar : PubMed/NCBI
92	Wang G, Liu L, Chen J, et al: Promoter methylation profile of androgen receptor gene in leukemic cells. J Third Mil Med Univ. 29:932–934. 2007.
93	Wang X, Li J, Fu B, Guo L, Zhang J and Huang S: Methylation Status of JunB and CDH13 gene promoter in CD34 CD38⁻chronic myelogenous leukemia cells. J Exp Hematol. 17:1405–1408. 2009.
94	Liu J: CDH13 gene promoter methylation and expression in acute myeloid leukemia. Master's degree dissertation, Guangzhou Medical University. 2013.
95	Wang Y: The study of DDIT3 gene promoter methylation in hematological tumors. Master's degree dissertation, Jiangsu University. 2009.
96	Zhu X, Zhu C, Wan Y, et al: Analysis of methylation of the Dickkopf1 (DKK-1) gene in acute leukemia. J Shandong Univ (Health Sci). 50:84–87. 2012.
97	Yuan X: The study of EDNRB gene promoter methylation in acute leukemia. Master's degree dissertation, Zhengzhou University. 2010.
98	Yu Y: The study of FANCF methylation in patients with acute myeloid leukemia and myelodysplastic syndrome. Master's degree dissertation, China Medical University. 2008.
99	Deng N: The study of FANCF/FANCD2 expression in patients with acute myeloid leukemia and myelodysplastic syndrome. Master's degree dissertation, China Medical University. 2009.
100	Qian Z: The significance of GRAF gene promoter methylation in hematopoietic tumors. Master's degree dissertation, Jiangsu University. 2010.
101	Chen Q: HAGE gene promoter hypomethylation in myeloid tumors. Master's degree dissertation, Jiangsu University. 2012.
102	Li Y, Wang Y, Zhou J, Zhou S, Fang G and Liu X: Analysis and clinical significance of hPer3 promoter methylation status for CML monitoring. Chin J Pathophysiol. 27:2111–2115. 2011.
103	Wang Y, Zhou J, Zhou S, et al: Promoter methylation status of hPer3 gene in AML patients and the in vitro effect of decitabine on the status. Chin J Hematol. 32:317–321. 2011.
104	Wang N: MiR-34b expression, methylation regulation and clinical significance in acute childhood leukemia. Master's degree dissertation, Suzhou University. 2013.
105	Chai H: RAGE-1 gene promoter hypomethylation in myeloid tumors. Master's degree dissertation, Shanxi Medical University. 2013.
106	Lin D, Fan R and Liu X: Significance of DNA methylation status of runx3 gene promoter region in acute leukemia. J Exp Hematol. 16:263–266. 2008.
107	Chim CS, Wong AS and Kwong YL: Epigenetic dysregulation of the Jak/STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias. Ann Hematol. 83:527–532. 2004. View Article : Google Scholar : PubMed/NCBI
108	Wang Y, Zhu CS, Bi KH, Xu WW, Dong L and Hou M: [Study of WIF-1 promoter methylation with expressions of β-catenin in acute leukemia]. Chin Med J. 91:2858–2860. 2011.
109	Liu W, Xu C, Guan M and Zhang Y: Aberrant promoter hypermethylation of AKAP12 gene in acute lymphoblastic leukemia in children. Lab Med. 23:344–348. 2008.
110	Gao F, Li Y, Liu W, et al: Studies on gene expression and the 5′ CpG islands methylation status of E-cadherin in acute myeloid leukemia. Chin J Hematol. 27:25–27. 2006.
111	Yao DM, Qian J, Lin J, et al: Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia. Leuk Res. 35:957–960. 2011. View Article : Google Scholar : PubMed/NCBI
112	Guan M, Xu C, Liu W and Chen B: Identification of aberrant methylation of DLC-1 by pyrosequencing in acute lymphoblastic leukemia in children. Chin J Lab Med. 31:389–393. 2008.
113	Yu L, Wang Q, Gu Q, Shi Z and Jin H: Study on aberrant DNA methylation of dopamine D4 receptor gene in acute myeloid leukemia. Acad J Chin PLA Postgrad Med Sch. 21:62–64. 2000.
114	Tao YF, Xu LX, Lu J, et al: Metallothionein III (MT3) is a putative tumor suppressor gene that is frequently inactivated in pediatric acute myeloid leukemia by promoter hypermethylation. J Transl Med. 12:1822014. View Article : Google Scholar : PubMed/NCBI
115	Zheng Y: Abnormal methylation of the promoter region of the p53 gene in acute leukemia. Master's degree dissertation, Sun Yat-sen University. 2007.
116	Li Y, Qian J, Chen Q, et al: Expression pattern and promoter hypermethylation of PDLIM4 gene in patients with chronic myeloid leukemia. J Jiangsu Univ (Med Ed.). 23:17–21. 2013.
117	Song JJ, Liu Q, Li Y, et al: Epigenetic inactivation of PLCD1 in chronic myeloid leukemia. Int J Mol Med. 30:179–184. 2012.PubMed/NCBI
118	Yao D, Qian J, Lin J, Li Y, Chen Q and Chen X: Alteration of methylation status of PRAME gene promoter in patients with chronic myeloid leukemia. J Pract Med. 29:3495–3498. 2013.
119	Yan W, Hu W and Yang W: Expression and methylation study of PRDX2 gene in acute myeloid leukemia. J China Med Univ. 41:1047–1049. 2012.
120	Yang J, Du W, He Y, Liu J, Zheng J and Huang S: Research on PTEN expression and its promoter methylation in B-ALL patients. J Intern Intens Med. 13:141–143. 2007.
121	Du C, Mao P and Wang Y: The clinical significance of the RIL gene methylation levels in acute myeloid leukemia. China J Mod Med. 23:46–51. 2013.
122	Jiao X, Chen Q, Lin J, et al: SALL4 genes methylation changes and clinical significance in acute myeloid leukemia patients. J Jiangsu Univ (Med Ed.). 23:532–535. 2013.
123	Zhuang Y, Cheng Y, Wang L, Dou H, Zhu Q and Hu J: The methylation of SOCS-1 gene in adult acute myeloid leukemia. Prog Mod Biomed. 18:3417–3420. 2011.
124	Deng G, Li ZQ, Zhao C, et al: WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation. Oncol Rep. 25:367–376. 2011.PubMed/NCBI
125	Iacobucci I, Ferrari A, Lonetti A, et al: CDKN2A/B alterations impair prognosis in adult BCR-ABL1-positive acute lymphoblastic leukemia patients. Clin Cancer Res. 17:7413–7423. 2011. View Article : Google Scholar : PubMed/NCBI
126	Hu HB and Hu Q: ID4 methylation patterns in childhood T line and B line lymphocytic leukemia. Chin J Contemp Pediatr. 12:940–942. 2010.(In Chinese).
127	Chen SS, Claus R, Lucas DM, et al: Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood. 117:862–871. 2011. View Article : Google Scholar : PubMed/NCBI
128	Liu Y, Kang HY, Wang LL, Lu XC, Zhu HL and Yu L: Establishment of methylation-specific quantitative PCR system for ID4 gene in acute leukemia cells and its specificity and sensitivity. J Exp Hematol. 22:269–274. 2014.(In Chinese).
129	Liu F and Xu RR: Study on the correlation between Chinese medical syndrome types and ID4 gene promoter methylation in human acute myeloid leukemia. Chin J Integr Tradit West Med. 32:471–473. 2012.(In Chinese).
130	Awasthi A, Woolley AG, Lecomte FJ, et al: Variable expression of GLIPR1 correlates with invasive potential in melanoma cells. Front Oncol. 3:2252013. View Article : Google Scholar : PubMed/NCBI
131	Capalbo G, Mueller-Kuller T, Koschmieder S, et al: Endoplasmic reticulum protein GliPR1 regulates G protein signaling and the cell cycle and is overexpressed in AML. Oncol Rep. 30:2254–2262. 2013.PubMed/NCBI
132	He Z, Liu H, Agostini M, et al: p73 regulates autophagy and hepatocellular lipid metabolism through a transcriptional activation of the ATG5 gene. Cell Death Differ. 20:1415–1424. 2013. View Article : Google Scholar : PubMed/NCBI
133	Toska E and Roberts SG: Mechanisms of transcriptional regulation by WT1 (Wilms tumour 1). Biochem J. 461:15–32. 2014. View Article : Google Scholar : PubMed/NCBI
134	Dores GM, Devesa SS, Curtis RE, Linet MS and Morton LM: Acute leukemia incidence and patient survival among children and adults in the United States, 2001–2007. Blood. 119:34–43. 2012. View Article : Google Scholar : PubMed/NCBI
135	Shirley MH, Sayeed S, Barnes I, Finlayson A and Ali R: Incidence of haematological malignancies by ethnic group in England, 2001-7. Br J Haematol. 163:465–477. 2013. View Article : Google Scholar : PubMed/NCBI